Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8443565 | European Journal of Cancer | 2014 | 11 Pages |
Abstract
This is the first integrated study that defined prognostic factors for SRS-treated patients with cerebral metastases using an inter-institutional validation study design. The work establishes a model for collaborative interactions between large volume centers and provides prognostic variables that should be incorporated into future clinical trial design.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
D.D. Gonda, T.E. Kim, S.J. Goetsch, T. Kawabe, S. Watanabe, J.F. Alksne, J.A. Hattangadi, M. Nitta, K. Ott, D.W. Hodgens, B.S. Carter, M. Yamamoto, Clark C. Chen,